Changes to our company portfolio – MSD and Organon & Co. read more
Changes to our company portfolio
Please note that as of June 3rd 2021, MSD completed the spin-off of products from its women’s health, legacy brands, and biosimilars franchises into the new independent, publicly traded company Organon & Co.
For information on former MSD products now transferred to Organon & Co. please visit their website.
AAH Customer Care
0344 561 8899
Visit the website
www.aah.co.uk
Supply Status
|
Product Description
|
Supply Status
|
Estimated Resupply Date
|
|
GARDASIL® (National Immunisation Programme)
|
N/A
|
Please refer to ImmForm for NIP supply status
|
|
GARDASIL®
|
Discontinued
|
|
|
GARDASIL® 9
|
Full Supply
|
|
|
VAQTA® Paediatric
|
Full Supply
|
|
|
VAQTA® Adult
|
Full Supply
|
|
|
HBVAXPRO®
5mcg
|
Full Supply
|
|
|
HBVAXPRO®
10mcg
|
Full Supply
|
|
|
HBVAXPRO®
40mcg
|
Full Supply
|
|
|
M-M-RVAXPRO® (National Immunisation Programme)
|
N/A
|
Please refer to ImmForm for NIP supply status
|
|
M-M-RVAXPRO®
|
Full Supply
|
|
|
PNEUMOVAX® 23 (pre-filled syringes) National Immunisation Programme
|
N/A
|
Please refer to ImmForm for NIP supply status
|
|
PNEUMOVAX® 23 (pre-filled syringes)
|
Full Supply
|
|
|
VARIVAX®
|
Full Supply
|
|
|
ZOSTAVAX® (National Immunisation Programme)
|
N/A
|
Please refer to ImmForm for NIP supply status
|
|
ZOSTAVAX®
|
Full Supply
|
|
This page is intended for use by UK healthcare professionals only. Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck & Co., Inc., Kenilworth, NJ, USA, its subsidiaries or affiliates, except as noted.
Job code: GB-NON-04922Date of preparation: October 2021